SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-21-014541
Filing Date
2021-03-10
Accepted
2021-03-10 14:53:46
Documents
17

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM F-1 ea137309-f1a4_universepharma.htm F-1/A 1954078
2 CONSENT OF FRIEDMAN LLP ea137309ex231_universepharma.htm EX-23.1 3662
3 GRAPHIC image_001.jpg GRAPHIC 33493
4 GRAPHIC image_002.jpg GRAPHIC 81053
5 GRAPHIC image_003.jpg GRAPHIC 24136
6 GRAPHIC image_004.jpg GRAPHIC 18618
7 GRAPHIC image_005.jpg GRAPHIC 14301
8 GRAPHIC image_006.jpg GRAPHIC 20017
9 GRAPHIC image_007.jpg GRAPHIC 19549
10 GRAPHIC image_008.jpg GRAPHIC 22074
11 GRAPHIC image_009.jpg GRAPHIC 2001
12 GRAPHIC image_010.jpg GRAPHIC 1876
13 GRAPHIC image_011.jpg GRAPHIC 1477
14 GRAPHIC image_012.jpg GRAPHIC 10611
15 GRAPHIC image_013.jpg GRAPHIC 10593
16 GRAPHIC logo_001.jpg GRAPHIC 57592
17 GRAPHIC logo_002.jpg GRAPHIC 3714
  Complete submission text file 0001213900-21-014541.txt   2403027
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: F-1/A | Act: 33 | File No.: 333-248067 | Film No.: 21729335
SIC: 2834 Pharmaceutical Preparations